Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Zhan JR"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wang MQ; Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Chen YR; Department of Gastroenterology, Zhujiang Hospital of Southern Medical University, Guangzhou, China., Xu HW; Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Zhan JR; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Suo DQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Wang JJ; Department of radiotherapy, Sun Yat-sen University Cancer Center, Guangzhou, China., Ma YZ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Guan XY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Departments of Clinical Oncology, The University of Hong Kong, Hong Kong, China., Li Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Zhu SL; Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Publikováno v:
Cancer science [Cancer Sci] 2023 Apr; Vol. 114 (4), pp. 1365-1377. Date of Electronic Publication: 2023 Jan 02.
Autor:
Zeng TT; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China., Deng TH; The Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine, 410006, Changsha, China., Liu Z; Hunan Academy of Traditional Chinese Medicine, 410006, Changsha, China., Zhan JR; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China., Ma YZ; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China., Yan YY; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 510120, Guangzhou, China.; Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, 528200, Foshan, China., Sun X; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 510120, Guangzhou, China.; Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, 528200, Foshan, China., Zhu YH; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China., Li Y; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China., Guan XY; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China. xyguan@hku.hk.; Department of Clinical Oncology, Shenzhen Key Laboratory for Metastasis and Personalized Therapy, The University of Hong Kong-Shenzhen Hospital, 518053, Shenzhen, China. xyguan@hku.hk.; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China. xyguan@hku.hk., Li L; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 510120, Guangzhou, China. lilei_728@163.com.; Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, 528200, Foshan, China. lilei_728@163.com.; Department of Clinical Oncology, Shenzhen Key Laboratory for Metastasis and Personalized Therapy, The University of Hong Kong-Shenzhen Hospital, 518053, Shenzhen, China. lilei_728@163.com.
Publikováno v:
Cell death & disease [Cell Death Dis] 2022 Dec 07; Vol. 13 (12), pp. 1026. Date of Electronic Publication: 2022 Dec 07.
Autor:
Shou C; State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, P.R. China., Zheng YC; State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, P.R. China., Zhan JR; State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, P.R. China., Li CX; State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, P.R. China., Xu JH; State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, P.R. China.
Publikováno v:
ChemSusChem [ChemSusChem] 2022 May 06; Vol. 15 (9), pp. e202101741. Date of Electronic Publication: 2021 Oct 13.
Autor:
Gerber PP; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Duncan LM; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Greenwood EJ; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Marelli S; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Naamati A; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Teixeira-Silva A; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Crozier TW; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Gabaev I; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Zhan JR; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Mulroney TE; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Horner EC; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Doffinger R; Department of Clinical Biochemistry and Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Willis AE; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Thaventhiran JE; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Protasio AV; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Matheson NJ; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.; NHS Blood and Transplant, Cambridge, United Kingdom.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2022 Feb 10; Vol. 18 (2), pp. e1010265. Date of Electronic Publication: 2022 Feb 10 (Print Publication: 2022).
Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection.
Autor:
Williams TL; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Colzani MT; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Macrae RGC; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Robinson EL; School of Medicine, Division of Cardiology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA., Bloor S; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Greenwood EJD; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Zhan JR; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Strachan G; Wellcome Trust-MRC Institute of Metabolic Science, Metabolic Research Laboratories, Addenbrooke's Biomedical Campus, Cambridge, UK., Kuc RE; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Nyimanu D; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Maguire JJ; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Lehner PJ; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Sinha S; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK. ss661@cam.ac.uk., Davenport AP; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. apd10@medschl.cam.ac.uk.
Publikováno v:
Communications biology [Commun Biol] 2021 Jul 29; Vol. 4 (1), pp. 926. Date of Electronic Publication: 2021 Jul 29.
Autor:
Chen QY; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Li YN; Westlake Institute for Advanced Study, Westlake University, Hangzhou, Zhejiang, P.R. China., Wang XY; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Zhang X; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Hu Y; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Li L; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Suo DQ; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Ni K; Westlake Institute for Advanced Study, Westlake University, Hangzhou, Zhejiang, P.R. China., Li Z; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Zhan JR; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Zeng TT; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Zhu YH; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Li Y; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China., Ma LJ; Westlake Institute for Advanced Study, Westlake University, Hangzhou, Zhejiang, P.R. China. xyguan@hku.hk malijia@westlake.edu.cn., Guan XY; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China. xyguan@hku.hk malijia@westlake.edu.cn.; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, P.R. China.
Publikováno v:
Cancer research [Cancer Res] 2020 Dec 15; Vol. 80 (24), pp. 5583-5596. Date of Electronic Publication: 2020 Oct 22.